论文信息 - A randomized phase III study of duration of anti-PD-1 therapy in metastatic melanoma (STOP-GAP): Canadian Clinical Trials Group study (CCTG) ME.13. - 字舞流文

A randomized phase III study of duration of anti-PD-1 therapy in metastatic melanoma (STOP-GAP): Canadian Clinical Trials Group study (CCTG) ME.13.

Bingshu E. Chen | K. Savage | J. Dancey | M. Smylie | Christopher W. Lee | N. Hong | E. McWhirter | T. Baetz | T. Petrella | D. Logan | D. Ernst | R. Wong | T. Abbas | Xinni Song | D. Nomikos | Muhammed Saleem Raza | R. Leung | E. Mcwhirter